Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: a case report
暂无分享,去创建一个
[1] Li Jiang,et al. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis. , 2019, Pediatric neurology.
[2] J. Zhao,et al. Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases , 2019, Front. Neurol..
[3] Massimiliano Valeriani,et al. Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis , 2019, Developmental medicine and child neurology.
[4] M. Lydolph,et al. Pediatric autoimmune encephalitis in Denmark during 2011-17: A nationwide multicenter population-based cohort study. , 2019, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[5] M. Veeravigrom,et al. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study , 2019, Brain and Development.
[6] M. Sprengers,et al. EBV-NMDA double positive encephalitis in an immunocompromised patient , 2019, Journal of the Neurological Sciences.
[7] Mayara de Rezende Machado,et al. Clinical variability of children with anti-N-methyl-d-aspartate receptor encephalitis in southern Brazil: a cases series and review of the literature , 2018, Neurological Sciences.
[8] M. Rajpurkar,et al. Pulmonary Embolism in Children. , 2018, Pediatric clinics of North America.
[9] V. Wong,et al. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong , 2018, Brain and Development.
[10] B. Boeve,et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis , 2018, Annals of neurology.
[11] B. Anlar,et al. Clinical presentation of anti-N-methyl-d-aspartate receptor and anti-voltage-gated potassium channel complex antibodies in children: A series of 24 cases. , 2018, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[12] Q. Lu,et al. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes , 2017, Journal of Neuroimmunology.
[13] K. Kaida,et al. Rituximab therapy and clinical management in anti-NMDA receptor antibody encephalitis refractory to first-line immunotherapy: Japanese case series , 2017, Journal of the Neurological Sciences.
[14] C. Juan,et al. Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis. , 2017, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[15] M. Steinschneider,et al. Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series. , 2017, Pediatric neurology.
[16] E. Amankwah,et al. Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics , 2017, Thrombosis and Haemostasis.
[17] D. Prabhakar,et al. Neuropsychiatric Presentation of Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Comorbid Sinus Venous Thrombosis. , 2016, The primary care companion for CNS disorders.
[18] K. Chu,et al. Frequent rhabdomyolysis in anti-NMDA receptor encephalitis , 2016, Journal of Neuroimmunology.
[19] E. Oguni,et al. Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. , 2016, JAMA neurology.
[20] A. Vincent,et al. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children , 2015, Archives of Disease in Childhood.
[21] F. Rosendaal,et al. The contribution of immobility risk factors to the incidence of venous thrombosis in an older population , 2014, Journal of thrombosis and haemostasis : JTH.
[22] 阪本 光. Details of treatment-related difficulties in men with anti-N-methyl D-aspartate receptor encephalitis , 2014 .
[23] J. Dalmau,et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. , 2013, The Journal of pediatrics.
[24] L. Honig,et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study , 2013, The Lancet Neurology.
[25] L. Honig,et al. Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study , 2013 .
[26] J. Schieveld,et al. Anti-NMDAR encephalitis: a new, severe and challenging enduring entity , 2013, European Child & Adolescent Psychiatry.
[27] S. Kusunoki,et al. Details of Treatment-Related Difficulties in Men with Anti-N-Methyl-d-Aspartate Receptor Encephalitis , 2012, European Neurology.
[28] C. Lucchinetti,et al. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. , 2011, Archives of neurology.
[29] A. Jacob,et al. N-methyl D-aspartate receptor encephalitis: A new addition to the spectrum of autoimmune encephalitis , 2011, Annals of Indian Academy of Neurology.
[30] J. Dalmau,et al. Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis. , 2010, Archives of neurology.
[31] M. Rosenfeld,et al. Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents , 2009, Annals of neurology.
[32] A. Hida,et al. RESPONSE OF ANTI-NMDA RECEPTOR ENCEPHALITIS WITHOUT TUMOR TO IMMUNOTHERAPY INCLUDING RITUXIMAB , 2008, Neurology.
[33] Xiaoyu Peng,et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.
[34] Josep Dalmau,et al. Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.